USFDA inspection at Tanuku plant ends with Form 483, six observations

Regulatory & Legal View source PDF Explain this filing

WANBURY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹340.95

prior close

₹328.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-0.3% vs market

Pharmaceuticals peers, median of 165sector+0.1%-0.1% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.6

10m

-1.3

15m

-2.9

30m

+2.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0+0.3-0.3+0.1-0.1

Next day

-3.1-0.9-2.3-1.5-1.7

-3.5-1.5-2.0-2.1-1.4

-2.6-1.1-1.5-2.2-0.4

-3.7+0.2-3.9-1.5-2.2

-8.5-1.1-7.4-2.2-6.3

-13.0-1.2-11.8-2.6-10.4

15d

-24.8+3.1-27.9+0.3-25.1

-22.5+4.5-27.0-0.4-22.1

-33.3+4.5-37.8+1.3-34.5

-45.3-2.2-43.1-5.8-39.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

USFDA conducted a routine cGMP inspection at Wanbury's Tanuku facility in Andhra Pradesh from July 13 to July 17, 2026. At the end of the inspection, the US regulator issued a Form 483 with six observations. The company will respond to these observations within the stipulated timeframe and will keep the stock exchanges informed of any further updates.

Likely market impact

Form 483 is a standard notice flagging procedural gaps, not a ban or import alert. Watch the company's response and any escalation to a warning letter.